{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:45:45Z","timestamp":1790430345547,"version":"4.1.0"},"reference-count":155,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Active targeting is a valuable and promising approach with which to enhance the therapeutic efficacy of nanodelivery systems, and the development of tumor-targeted nanoparticles has therefore attracted much research attention. In this field, the research carried out in Italian Pharmaceutical Technology academic groups has been focused on the development of actively targeted nanosystems using a multidisciplinary approach. To highlight these efforts, this review reports a thorough description of the last 10 years of Italian research results on the development of actively targeted nanoparticles to direct drugs towards different receptors that are overexpressed on cancer cells or in the tumor microenvironment. In particular, the review discusses polymeric nanocarriers, liposomes, lipoplexes, niosomes, solid lipid nanoparticles, squalene nanoassemblies and nanobubbles. For each nanocarrier, the main ligands, conjugation strategies and target receptors are described. The literature indicates that polymeric nanoparticles and liposomes stand out as key tools for improving specific drug delivery to the site of action. In addition, solid lipid nanoparticles, squalene nanoparticles and nanobubbles have also been successfully proposed. Taken together, these strategies all offer many platforms for the design of nanocarriers that are suitable for future clinical translation.<\/jats:p>","DOI":"10.3390\/pharmaceutics13101538","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T22:50:48Z","timestamp":1632351048000},"page":"1538","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-7460","authenticated-orcid":false,"given":"Monica","family":"Argenziano","sequence":"first","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4754-6591","authenticated-orcid":false,"given":"Silvia","family":"Arpicco","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Brusa","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Cavalli","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4615-5812","authenticated-orcid":false,"given":"Daniela","family":"Chirio","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1128-9922","authenticated-orcid":false,"given":"Franco","family":"Dosio","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-1672","authenticated-orcid":false,"given":"Marina","family":"Gallarate","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-4956","authenticated-orcid":false,"given":"Elena","family":"Peira","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-6604","authenticated-orcid":false,"given":"Barbara","family":"Stella","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-0675","authenticated-orcid":false,"given":"Elena","family":"Ugazio","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/1061186X.2015.1051049","article-title":"Nanocarriers for cancer-targeted drug delivery","volume":"24","author":"Kumari","year":"2015","journal-title":"J. Drug Target."},{"key":"ref_2","first-page":"1","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jconrel.2020.10.003","article-title":"Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation","volume":"329","author":"Gu","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tang, L., Li, J., Zhao, Q., Pan, T., Zhong, H., and Wang, W. (2021). Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081151"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/21691401.2018.1457039","article-title":"Nanoparticles as carriers for drug delivery in cancer","volume":"46","author":"Dadwal","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/acs.bioconjchem.9b00456","article-title":"Insights into active targeting of nanoparticles in drug delivery: Advances in clinical studies and design considerations for cancer nanomedicine","volume":"30","author":"Pearce","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.drudis.2020.09.031","article-title":"Recent advances in targeted nanomedicine as promising antitumor therapeutics","volume":"25","author":"Hejmady","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska, A., Szalata, M., Gorczy\u0144ski, A., Karczewski, J., Eder, P., Severino, P., Cabeda, J., Souto, E., and S\u0142omski, R. (2021). Cancer nanopharmaceuticals: Physicochemical characterization and in vitro\/in vivo applications. Cancers, 13.","DOI":"10.3390\/cancers13081896"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1158\/1078-0432.CCR-18-2381","article-title":"Intracellular delivery of an antibody targeting gasdermin-B Reduces HER2 breast cancer aggressiveness","volume":"25","author":"Cadete","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/17425247.2016.1244187","article-title":"Nanoparticle-based drug delivery systems: A commercial and regulatory outlook as the field matures","volume":"14","author":"Ragelle","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2014.03.057","article-title":"EPR: Evidence and fallacy","volume":"190","author":"Nichols","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2019.11.002","article-title":"Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy","volume":"69","author":"Raj","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrclinonc.2009.52","article-title":"Anticancer strategies involving the vasculature","volume":"6","author":"Heath","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","article-title":"Active targeting schemes for nanoparticle systems in cancer therapeutics","volume":"60","author":"Byrne","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","article-title":"Cancer active targeting by nanoparticles: A comprehensive review of literature","volume":"141","author":"Bazak","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: A systematic review","volume":"13","author":"Muhamad","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","article-title":"Safety and efficacy of bind-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer","volume":"4","author":"Autio","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/mco.2014.356","article-title":"Passive targeting of nanoparticles to cancer: A comprehensive review of the literature","volume":"2","author":"Bazak","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"129777","DOI":"10.1016\/j.bbagen.2020.129777","article-title":"Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead","volume":"1865","author":"Akhter","year":"2020","journal-title":"Biochim. et Biophys. Acta BBA-Gen. Subj."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","article-title":"Targeted anticancer therapy: Overexpressed receptors and nanotechnology","volume":"436","author":"Akhtar","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1470-2045(15)00039-X","article-title":"Multifunctional receptor-targeting antibodies for cancer therapy","volume":"16","author":"Zhu","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105544","DOI":"10.1016\/j.phrs.2021.105544","article-title":"Ligand decorated biodegradable nanomedicine in the treatment of cancer","volume":"167","author":"Ahmad","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jconrel.2020.09.055","article-title":"Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment","volume":"329","author":"Sonju","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2006.08.039","article-title":"Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells","volume":"329","author":"Kobayashi","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.jddst.2019.101133","article-title":"Alendronate-modified polydopamine-coated paclitaxel nanoparticles for osteosarcoma-targeted therapy","volume":"53","author":"Lei","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"120404","DOI":"10.1016\/j.biomaterials.2020.120404","article-title":"Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges","volume":"265","author":"Gao","year":"2020","journal-title":"Biomaterials"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI116001","article-title":"Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha","volume":"90","author":"Korc","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-1-11","article-title":"The epidermal growth factor receptor (EGFR) in head and neck cancer: Its role and treatment implications","volume":"1","author":"Zimmermann","year":"2006","journal-title":"Radiat. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.26436","article-title":"Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma","volume":"118","author":"Minner","year":"2011","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/cncr.10372","article-title":"Monoclonal antibodies to target epidermal growth factor receptor-positive tumors","volume":"94","author":"Herbst","year":"2002","journal-title":"Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2017.00018","article-title":"CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells","volume":"5","author":"Senbanjo","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03037-0","article-title":"CD44\/HA signaling mediates acquired resistance to a PI3K\u03b1 inhibitor","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/annonc\/mdv250","article-title":"Targeting the folate receptor: Diagnostic and therapeutic approaches to personalize cancer treatments","volume":"26","author":"Ledermann","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-nutr-072610-145133","article-title":"Mechanisms of membrane transport of folates into cells and across epithelia","volume":"31","author":"Zhao","year":"2011","journal-title":"Annu. Rev. Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jcb.10661","article-title":"Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer","volume":"91","author":"Ghosh","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymeth.2017.06.026","article-title":"PSMA ligands in prostate cancer\u2014Probe optimization and theranostic applications","volume":"130","author":"Slavik","year":"2017","journal-title":"Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10837450.2021.1875238","article-title":"Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel","volume":"26","author":"Saniee","year":"2021","journal-title":"Pharm. Dev. Technol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1357-2725(99)00070-9","article-title":"The transferrin receptor: Role in health and disease","volume":"31","author":"Ponka","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","article-title":"The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Saxena, M., Delgado, Y., Sharma, R.K., Sharma, S., Guzm\u00e1n, S.L.P.D.L., Tinoco, A.D., and Griebenow, K. (2018). Inducing cell death in vitro in cancer cells by targeted delivery of cytochrome c via a transferrin conjugate. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195542"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fimmu.2021.607692","article-title":"Antibodies targeting the transferrin receptor 1 (TfR1) as direct anti-cancer agents","volume":"12","author":"Candelaria","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/10717544.2018.1435747","article-title":"Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer","volume":"25","author":"Deshpande","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Soe, Z.C., Kwon, J.B., Thapa, R.K., Ou, W., Nguyen, H.T., Gautam, M., Oh, K.T., Choi, H.-G., Ku, S.K., and Yong, C.S. (2019). Transferrin-conjugated polymeric nanoparticle for receptor-mediated delivery of doxorubicin in doxorubicin-resistant breast cancer cells. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11020063"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109923","DOI":"10.1016\/j.msec.2019.109923","article-title":"Biotin-targeted mixed liposomes: A smart strategy for selective release of a photosensitizer agent in cancer cells","volume":"104","author":"Montanha","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1039\/C5CC03075G","article-title":"Recent development of biotin conjugation in biological imaging, sensing, and target delivery","volume":"51","author":"Ren","year":"2015","journal-title":"Chem. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/10717544.2017.1378940","article-title":"Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy","volume":"24","author":"Wang","year":"2017","journal-title":"Drug Deliv."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.ymthe.2017.04.023","article-title":"Antitumoral cascade-targeting ligand for il-6 receptor-mediated gene delivery to glioma","volume":"25","author":"Wang","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fendo.2011.00093","article-title":"The Insulin Receptor: A new target for cancer therapy","volume":"2","author":"Malaguarnera","year":"2011","journal-title":"Front. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1039\/C2CS35265F","article-title":"Design, functionalization strategies and biomedical applications of targeted biodegradable\/biocompatible polymer-based nanocarriers for drug delivery","volume":"42","author":"Nicolas","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mazzotta, E., De Benedittis, S., Qualtieri, A., and Muzzalupo, R. (2019). Actively targeted and redox responsive delivery of anticancer drug by chitosan nanoparticles. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010026"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1039\/C3PY00744H","article-title":"Synthesis and characterization of variable conformation pH responsive block co-polymers for nucleic acid delivery and targeted cell entry","volume":"5","author":"Matini","year":"2014","journal-title":"Polym. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1021\/acs.biomac.5b00286","article-title":"Triblock copolymer nanovesicles for pH-responsive targeted delivery and controlled release of siRNA to cancer cells","volume":"16","author":"Gallon","year":"2015","journal-title":"Biomacromolecules"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Curcio, M., Paol\u00ec, A., Cirillo, G., Di Pietro, S., Forestiero, M., Giordano, F., Mauro, L., Amantea, D., Di Bussolo, V., and Nicoletta, F. (2021). Combining dextran conjugates with stimuli-responsive and folate-targeting activity: A new class of multifunctional nanoparticles for cancer therapy. Nanomaterials, 11.","DOI":"10.3390\/nano11051108"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejps.2017.09.048","article-title":"Shedding light on surface exposition of poly(ethylene glycol) and folate targeting units on nanoparticles of poly(\u03b5-caprolactone) diblock copolymers: Beyond a paradigm","volume":"111","author":"Venuta","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.colsurfb.2016.01.035","article-title":"Cyclodextrin-assisted assembly of PEGylated polyester nanoparticles decorated with folate","volume":"141","author":"Conte","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1039\/D0PY00158A","article-title":"Nanoparticles decorated with folate based on a site-selective \u03b1CD-rotaxanated PEG-b-PCL copolymer for targeted cancer therapy","volume":"11","author":"Poggetto","year":"2020","journal-title":"Polym. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Chiesa, E., Dorati, R., Conti, B., Modena, T., Cova, E., Meloni, F., and Genta, I. (2018). Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082310"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chiesa, E., Riva, F., Dorati, R., Greco, A., Ricci, S., Pisani, S., Patrini, M., Modena, T., Conti, B., and Genta, I. (2020). On-Chip synthesis of hyaluronic acid-based nanoparticles for selective inhibition of CD44+ human mesenchymal stem cell proliferation. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030260"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Curcio, M., Diaz-Gomez, L., Cirillo, G., Nicoletta, F., Leggio, A., and Iemma, F. (2021). Dual-targeted hyaluronic acid\/albumin micelle-like nanoparticles for the vectorization of doxorubicin. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030304"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ijbiomac.2019.03.241","article-title":"Sclareol-loaded hyaluronan-coated PLGA nanoparticles: Physico-chemical properties and in vitro anticancer features","volume":"132","author":"Cosco","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-015-0088-2","article-title":"Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells","volume":"13","author":"Maiolino","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"79670","DOI":"10.18632\/oncotarget.13216","article-title":"Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles","volume":"7","author":"Russo","year":"2016","journal-title":"Oncotarget"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1021\/acs.molpharmaceut.8b00597","article-title":"Co-delivery of docetaxel and disulfonate tetraphenyl chlorin in one nanoparticle produces strong synergism between chemo- and photodynamic therapy in drug-sensitive and -resistant cancer cells","volume":"15","author":"Gaio","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Gaio, E., Conte, C., Esposito, D., Reddi, E., Quaglia, F., and Moret, F. (2020). CD44 targeting mediated by polymeric nanoparticles and combination of chlorine TPCS2a-PDT and docetaxel-chemotherapy for efficient killing of breast differentiated and stem cancer cells in vitro. Cancers, 12.","DOI":"10.3390\/cancers12020278"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1039\/C4NR06910B","article-title":"Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo\/chemo-therapy of cancer","volume":"7","author":"Maiolino","year":"2015","journal-title":"Nanoscale"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2016.06.118","article-title":"Biotin-targeted Pluronic \u00ae P123\/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells","volume":"511","author":"Russo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msec.2016.09.064","article-title":"Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells","volume":"71","author":"Pellosi","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.msec.2019.04.054","article-title":"Biodegradable nanoparticles exposing a short anti-FLT1 peptide as antiangiogenic platform to complement docetaxel anticancer activity","volume":"102","author":"Conte","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1158\/1078-0432.CCR-13-0015","article-title":"nanoparticles engineered with rituximab and loaded with nutlin-3 show promising therapeutic activity in b-leukemic xenografts","volume":"19","author":"Voltan","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2015.05.029","article-title":"Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma","volume":"490","author":"Belletti","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1021\/acsomega.9b02086","article-title":"Real-time label-free targeting assessment and in vitro characterization of curcumin-loaded poly-lactic-co-glycolic acid nanoparticles for oral colon targeting","volume":"4","author":"Akl","year":"2019","journal-title":"ACS Omega"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ijpharm.2016.08.011","article-title":"Design of smart GE11-PLGA\/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: Synthesis, preparation and in vitro\/ex vivo characterization","volume":"511","author":"Colzani","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1021\/mp400536z","article-title":"translocator protein ligand\u2013plga conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells","volume":"11","author":"Laquintana","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jconrel.2013.09.024","article-title":"In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM\u2013FITC labeled dendrimer","volume":"172","author":"Denora","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijpharm.2017.06.049","article-title":"Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers","volume":"528","author":"Iacobazzi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/156800910793605767","article-title":"Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases","volume":"10","author":"Salerno","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1163\/092050611X580373","article-title":"The effect of poly(d,l-lactide-co-glycolide)-alendronate conjugate nanoparticles on human osteoclast precursors","volume":"23","author":"Cenni","year":"2012","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/mp2001445","article-title":"Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms","volume":"8","author":"Clementi","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4155\/tde.15.92","article-title":"Nanobubbles: A promising efficient tool for therapeutic delivery","volume":"7","author":"Cavalli","year":"2016","journal-title":"Ther. Deliv."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"586874","DOI":"10.3389\/fbioe.2020.586874","article-title":"Tumor targeted multifunctional magnetic nanobubbles for MR\/US dual imaging and focused ultrasound triggered drug delivery","volume":"8","author":"Jin","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fmats.2020.549002","article-title":"Preparation and ultrasonic imaging investigation of perfluoropentane-filled polylactic acid nanobubbles as a novel targeted ultrasound contrast agent","volume":"7","author":"Xiao","year":"2020","journal-title":"Front. Mater."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.biomaterials.2009.11.052","article-title":"Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging","volume":"31","author":"Xu","year":"2010","journal-title":"Biomaterials"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1016\/j.biomaterials.2014.02.036","article-title":"Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and synergistic targeted therapy of residual tumor during HIFU ablation","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"ref_86","unstructured":"Capolla, S., Argenziano, M., Bozzer, S., D\u2019Agaro, T., Bittolo, T., De Leo, L., Not, T., Busato, D., Dal Bo, M., and Toffoli, G. (2021). Targeted chitosan nanobubbles as a new delivery approach required for anti-microRNA-17 based systemic therapy in Burkitt lymphoma models. Small, submitted for publication."},{"key":"ref_87","unstructured":"Argenziano, M., Occhipinti, S., Guiot, C., Giovarelli, M., and Cavalli, R. (2017, January 26\u201328). Nanobubble-based HER2 immunotherapy through dendritic cells targeting. Presented at the CRS Italy Chapter Workshop 2017, Padova, Italy."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(98)00006-4","article-title":"Lipophilic drug derivatives in liposomes","volume":"165","author":"Gulati","year":"1998","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: Advancements and innovation in the manufacturing process","volume":"154\u2013155","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"120346","DOI":"10.1016\/j.ijpharm.2021.120346","article-title":"LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy","volume":"597","author":"Torrieri","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40259-013-0048-z","article-title":"peptide-mediated targeting of cytokines to tumor vasculature: The NGR-hTNF Example","volume":"27","author":"Corti","year":"2013","journal-title":"BioDrugs"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2015.05.286","article-title":"Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma","volume":"211","author":"Zuccari","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2013.06.015","article-title":"Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma","volume":"170","author":"Pastorino","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/IJN.S29242","article-title":"Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: A potential theranostic agent","volume":"7","author":"Morelli","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/1061186X.2012.741138","article-title":"Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells","volume":"21","author":"Accardo","year":"2012","journal-title":"J. Drug Target."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1039\/C5NR06335C","article-title":"CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis","volume":"8","author":"Portella","year":"2016","journal-title":"Nanoscale"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10557-005-6899-x","article-title":"Urotensin II: Its function in health and its role in disease","volume":"19","author":"Ong","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9293560","article-title":"Urotensin-II-targeted liposomes as a new drug delivery system towards prostate and colon cancer cells","volume":"2019","author":"Zappavigna","year":"2019","journal-title":"J. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s11671-018-2807-8","article-title":"Decoration of Nanovesicles with pH (Low) Insertion Peptide (pHLIP) for Targeted Delivery","volume":"13","author":"Rinaldi","year":"2018","journal-title":"Nanoscale Res. Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09687688.2017.1342969","article-title":"pH-sensitive pHLIP\u00ae coated niosomes","volume":"33","author":"Pereira","year":"2016","journal-title":"Mol. Membr. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","article-title":"Non-ionic surfactant based vesicles (niosomes) in drug delivery","volume":"172","author":"Uchegbu","year":"1998","journal-title":"Int. J. Pharm."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0021-9797(90)90348-R","article-title":"On the thermodynamic stability of liposomes","volume":"140","author":"Lasic","year":"1990","journal-title":"J. Colloid Interface Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1467-2494.1979.tb00224.x","article-title":"Dispersions of lamellar phases of non-ionic lipids in cosmetic products","volume":"1","author":"Ribier","year":"1979","journal-title":"Int. J. Cosmet. Sci."},{"key":"ref_106","first-page":"1000","article-title":"New drug delivery systems","volume":"20","author":"Florence","year":"1993","journal-title":"Chem. Ind."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/abm-2018-0002","article-title":"Niosomes: A review of their structure, properties, methods of preparation, and medical applications","volume":"11","author":"Yeo","year":"2017","journal-title":"Asian Biomed."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4103\/0110-5558.76435","article-title":"Niosome: A future of targeted drug delivery systems","volume":"1","author":"Kuotsu","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bbamem.2013.01.020","article-title":"Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity","volume":"1828","author":"Pozza","year":"2013","journal-title":"Biochim. et Biophys. Acta (BBA) Biomembr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejpb.2013.06.003","article-title":"Hyaluronic acid-coated liposomes for active targeting of gemcitabine","volume":"85","author":"Arpicco","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbagen.2018.09.018","article-title":"Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes","volume":"1863","author":"Marengo","year":"2018","journal-title":"Biochim. et Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2019.04.029","article-title":"Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive\/doxorubicin-resistant osteosarcoma cells and xenografts","volume":"456","author":"Gazzano","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"116798","DOI":"10.1016\/j.carbpol.2020.116798","article-title":"Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells","volume":"248","author":"Cano","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"120291","DOI":"10.1016\/j.ijpharm.2021.120291","article-title":"Strategies for cancer gene-delivery improvement by non-viral vectors","volume":"596","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"105032","DOI":"10.1016\/j.chemphyslip.2020.105032","article-title":"Cationic lipids for gene delivery: Many players, one goal","volume":"235","author":"Ponti","year":"2021","journal-title":"Chem. Phys. Lipids"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/mp800215d","article-title":"Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells","volume":"4","author":"Surace","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jconrel.2012.07.015","article-title":"Hyaluronic acid-bearing lipoplexes: Physico-chemical characterization and in vitro targeting of the CD44 receptor","volume":"162","author":"Wojcicki","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/oli.2008.0168","article-title":"Hyaluronic acid-modified DOTAP\/dope liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells","volume":"19","author":"Taetz","year":"2009","journal-title":"Oligonucleotides"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2016.06.125","article-title":"Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model","volume":"514","author":"Nascimento","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"11186","DOI":"10.1021\/acs.langmuir.5b01979","article-title":"Supramolecular organization and siRNA binding of hyaluronic acid-coated lipoplexes for targeted delivery to the CD44 receptor","volume":"31","author":"Nascimento","year":"2015","journal-title":"Langmuir"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/cmdc.201500586","article-title":"Enhanced efficacy of artemisinin loaded in transferrin-conjugated liposomes versus stealth liposomes against HCT-8 colon cancer cells","volume":"11","author":"Leto","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2010.10.046","article-title":"Self-assembly nanoparticles for the delivery of bisphosphonates into tumors","volume":"403","author":"Salzano","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1021\/acs.molpharmaceut.7b01085","article-title":"Structural characterization of self-assembling hybrid nanoparticles for bisphosphonate delivery in tumors","volume":"15","author":"Ristori","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.18632\/oncotarget.2182","article-title":"Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid","volume":"5","author":"Porru","year":"2014","journal-title":"Oncotarget"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1166\/jbn.2016.2214","article-title":"Transferrin-targeted nanoparticles containing zoledronic acid as a potential tool to inhibit glioblastoma growth","volume":"12","author":"Salzano","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/217365","article-title":"Transferrin-Conjugated SNALPs Encapsulating 2\u2032-O-Methylated miR-34a for the Treatment of Multiple Myeloma","volume":"2014","author":"Scognamiglio","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"12638","DOI":"10.1021\/la4021383","article-title":"Transferrin-Conjugated Pluronic Niosomes as a New Drug Delivery System for Anticancer Therapy","volume":"29","author":"Tavano","year":"2013","journal-title":"Langmuir"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.1021\/acs.langmuir.6b02063","article-title":"further evolution of multifunctional niosomes based on pluronic surfactant: Dual active targeting and drug combination properties","volume":"32","author":"Tavano","year":"2016","journal-title":"Langmuir"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2012.06.001","article-title":"Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model","volume":"82","author":"Paolino","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2015.04.009","article-title":"A comparative study of folate receptor-targeted doxorubicin delivery systems: Dosing regimens and therapeutic index","volume":"208","author":"Scomparin","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2017.11.042","article-title":"Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors","volume":"270","author":"Gazzano","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_132","first-page":"2642","article-title":"Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells","volume":"45","author":"Cheung","year":"1985","journal-title":"Cancer Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<268::AID-IJC17>3.0.CO;2-1","article-title":"GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide","volume":"81","author":"Pagnan","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4161\/cbt.28875","article-title":"Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies","volume":"15","author":"Brown","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Scavo, M.P., Cutrignelli, A., DePalo, N., Fanizza, E., Laquintana, V., Gasparini, G., Giannelli, G., and Denora, N. (2020). Effectiveness of a controlled 5-FU delivery based on FZD10 antibody-conjugated liposomes in colorectal cancer in vitro models. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12070650"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2217\/nnm.10.83","article-title":"Immunoliposomal systems targeting primary effusion lymphoma: In vitro study","volume":"5","author":"Ruozi","year":"2010","journal-title":"Nanomedicine"},{"key":"ref_137","first-page":"1","article-title":"Functionalization of liposomes: Microscopical methods for preformulative screening","volume":"25","author":"Belletti","year":"2014","journal-title":"J. Liposome Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"184","DOI":"10.18433\/J3230M","article-title":"Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting","volume":"15","author":"Bragagni","year":"2012","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"17646","DOI":"10.1021\/acsami.8b03469","article-title":"pH-controlled liposomes for enhanced cell penetration in tumor environment","volume":"10","author":"Barattin","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"120012","DOI":"10.1016\/j.ijpharm.2020.120012","article-title":"Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency","volume":"592","author":"Popilski","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1471-4159.2008.05628.x","article-title":"Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation","volume":"107","author":"Iwamaru","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijpharm.2017.12.048","article-title":"A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine","volume":"537","author":"Pireddu","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1210\/jc.2003-030586","article-title":"correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas","volume":"88","author":"Daumerie","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1016\/j.biomaterials.2014.04.088","article-title":"Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes","volume":"35","author":"Paolino","year":"2014","journal-title":"Biomaterials"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Duong, V.-A., Nguyen, T.-T., and Maeng, H.-J. (2020). Preparation of Solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules, 25.","DOI":"10.3390\/molecules25204781"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2017.01.039","article-title":"ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier","volume":"249","author":"Magro","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.biomaterials.2007.06.011","article-title":"Active targeting of brain tumors using nanocarriers","volume":"28","author":"Saulnier","year":"2007","journal-title":"Biomaterials"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4103\/0250-474X.100253","article-title":"Colloidal dispersions for the delivery of acyclovir: A comparative study","volume":"73","author":"Cortesi","year":"2011","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/nnm-2016-0380","article-title":"Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: Preliminary study for glioma treatment","volume":"12","author":"Battaglia","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Muntoni, E., Martina, K., Marini, E., Giorgis, M., Lazzarato, L., Salaroglio, I.C., Riganti, C., Lanotte, M., and Battaglia, L. (2019). Methotrexate-loaded solid lipid nanoparticles: Protein functionalization to improve brain biodistribution. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11020065"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jconrel.2011.07.038","article-title":"Squalenoylation: A generic platform for nanoparticular drug delivery","volume":"161","author":"Gref","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.06.039","article-title":"Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor","volume":"192","author":"Valetti","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1021\/bc5003423","article-title":"Peptide Conjugation: Before or After Nanoparticle Formation?","volume":"25","author":"Valetti","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Chirio, D., Peira, E., Sapino, S., Chindamo, G., Oliaro-Bosso, S., Adinolfi, S., Dianzani, C., Baratta, F., and Gallarate, M. (2021). A new bevacizumab carrier for intravitreal administration: Focus on stability. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040560"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/10\/1538\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:03:25Z","timestamp":1760166205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/10\/1538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":155,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["pharmaceutics13101538"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13101538","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}